Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Corcept (CORT) Upgraded to Buy: Here's Why
01:01pm, Tuesday, 27'th Aug 2024
Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Corcept Therapeutics Incorporated (NASDAQ: CORT) on behalf of the company's shareholders. The inve
Wall Street Analysts Believe Corcept (CORT) Could Rally 70.58%: Here's is How to Trade
10:55am, Friday, 16'th Aug 2024
The consensus price target hints at a 70.6% upside potential for Corcept (CORT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
5 Small Drug Stocks to Buy as Innovation Reaches Peak
09:20am, Friday, 16'th Aug 2024
Innovation is at its peak for the Zacks Medical-Drugs industry. CORT, AMRX, BVS, FHTX, and AKBA may prove to be good additions to one's portfolio.
Corcept Therapeutics Incorporated (CORT) Hits Fresh High: Is There Still Room to Run?
10:15am, Thursday, 01'st Aug 2024
Corcept (CORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Can Corcept (CORT) Run Higher on Rising Earnings Estimates?
01:20pm, Wednesday, 31'st Jul 2024
Corcept (CORT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Are You Looking for a Top Momentum Pick? Why Corcept Therapeutics (CORT) is a Great Choice
01:01pm, Wednesday, 31'st Jul 2024
Does Corcept Therapeutics (CORT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts See a 37.6% Upside in Corcept (CORT): Can the Stock Really Move This High?
10:56am, Wednesday, 31'st Jul 2024
The consensus price target hints at a 37.6% upside potential for Corcept (CORT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Corcept Therapeutics: Q2 Gains Overshadowed By Generic Competition And Speculative Pipeline
02:36pm, Tuesday, 30'th Jul 2024
Corcept Therapeutics' strong Q2 earnings exceed expectations, with revenue climbing 39% YoY and EPS beating analyst estimates. The District Court ruled in favor of Teva, enabling the launch of a gener
Corcept (CORT) Q2 Earnings & Revenues Surpass Estimates
11:45am, Tuesday, 30'th Jul 2024
Corcept (CORT) beats on both earnings and sales in the second quarter of 2024. The company increases revenue guidance for 2024.
Corcept Therapeutics Incorporated (CORT) Q2 2024 Earnings Call Transcript
09:22pm, Monday, 29'th Jul 2024
Corcept Therapeutics Incorporated (NASDAQ:CORT ) Q2 2024 Earnings Conference Call July 29, 2024 5:00 PM ET Company Participants Atabak Mokari - Chief Financial Officer Charles Robb - Chief Business Of
Corcept Therapeutics (CORT) Q2 Earnings and Revenues Beat Estimates
06:56pm, Monday, 29'th Jul 2024
Corcept Therapeutics (CORT) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.25 per share a year ago.
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
04:05pm, Monday, 22'nd Jul 2024
MENLO PARK, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on
Navigate Market Turbulence With These 4 Low-Beta Stocks
09:10am, Thursday, 18'th Jul 2024
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Cool Company (CLCO), Corcept Therapeutics (CORT), TXO Partners (TXO), & JOYY (YY) are well-poised to gain.
5 Stocks With Recent Price Strength to Tap Wall Street Rally
08:01am, Wednesday, 17'th Jul 2024
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ADMA, AMSC, BTMD, LINC, CORT.
